logo

Olema Pharmaceuticals Inc Inc. (OLMA) Price Performance: A Technical Analysis Perspective

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -27.51%. However, over the last six months, the performance has been stronger by -35.75%. The price of OLMA decreased -6.27% over the last 30 days. And in the last five days, it has fallen by -9.52%.

Olema Pharmaceuticals Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $17.79 on 11/08/23, and the lowest price during that time was $5.02, recorded on 05/30/23.

52-week price history of OLMA Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Olema Pharmaceuticals Inc’s current trading price is -42.84% away from its 52-week high, while its distance from the 52-week low is 102.59%. The stock’s price range for this period has been between $5.02 and $17.79. The Healthcare sector company’s shares saw a trading volume of about 0.95 million for the day, which was higher than the average daily volume of 0.82 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Olema Pharmaceuticals Inc (OLMA) has experienced a quarterly decline of -34.26% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 568.81M and boasts a workforce of 74 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 12.20, with a change in price of -3.35. Similarly, Olema Pharmaceuticals Inc recorded 759,242 in trading volume during the last 100 days, posting a change of -24.78%.

OLMA’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for OLMA stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.

OLMA Stock Stochastic Average

As of today, the raw stochastic average of Olema Pharmaceuticals Inc over the past 50 days is 17.87%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 45.09%. Additionally, the Stochastic %K and %D values for the company were 18.30% and 20.81%, respectively, over the past 20 days.

Most Popular